A prospective study to investigate the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei
- Conditions
- pseudomyxoma peritonei
- Registration Number
- JPRN-UMIN000011384
- Lead Sponsor
- ational Center for Global Health and Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 75
Not provided
1) Patient who has a history of multiple cancers within 5 years before registration, with the exception of carcinoma in situ and a disease equivalent of intramucosal carcinoma. 2) Patient who is associated with unstable angina pectoris that occurred or worsened within 3 weeks before registration, or patient with a history of cardiac infarction that developed within 6 months before registration. 3) Patient with serious diseases including uncontrolled congestive cardiac failure and abnormal cardiac rhythm. 4) Patient who is associated with or has a history of either fibroid lung or interstitial pneumonia or both. Patient with imaging findings suggestive of the diseases. 5) Patient who is pregnant or breast feeding, or who refuses to use appropriate birth control. 6) Patient whose consent is suspicious in terms of his/her mental and legal state. 7) Patient who is considered by the investigator to be unsuitable for enrollment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival (5 years)
- Secondary Outcome Measures
Name Time Method Disease-free survival, recurrence-free survival and frequency and grade of adverse events